Braun-Bostich & Associates’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-39
Closed -$14K 289
2020
Q2
$14K Buy
39
+10
+34% +$3.22K 0.01% 196
2020
Q1
$7K Hold
29
0.01% 235
2019
Q4
$9K Buy
+29
New +$8.79K 0.01% 250
2019
Q3
Sell
-29
Closed -$10K 192
2019
Q2
$10K Hold
29
0.01% 265
2019
Q1
$9K Hold
29
0.01% 272
2018
Q4
$8K Hold
29
0.01% 267
2018
Q3
$10K Hold
29
0.01% 263
2018
Q2
$8K Hold
29
0.01% 263
2018
Q1
$7K Hold
29
0.01% 278
2017
Q4
$6K Buy
+29
New +$5.97K 0.01% 270

Other funds holding ILMN

Braun-Bostich & Associates's ILMN Position: Q3 2020 in Review

Braun-Bostich & Associates sold out of Illumina (ILMN) in Q3 2020, closing a stake of 39 shares — an estimated $14K sold.

Braun-Bostich & Associates first reported a position in ILMN in Q4 2017 and held it in 10 quarters. The position peaked at $14K in Q2 2020. 898 funds tracked by Wall St. Rank hold ILMN as of Q3 2020.

  • Braun-Bostich & Associates reported no remaining Illumina position as of Q3 2020 after selling out during the quarter.
  • Braun-Bostich & Associates sold 39 Illumina shares in Q3 2020, an estimated $14K.
  • Braun-Bostich & Associates first reported a position in Illumina in Q4 2017 and held it in 10 quarters.
  • Braun-Bostich & Associates's Illumina position peaked at $14K in Q2 2020.
  • 898 funds tracked by Wall St. Rank held Illumina as of Q3 2020.

Based on Braun-Bostich & Associates's 13F filing for Q3 2020, filed 9 Oct 2020.